Statins are associated with a lower risk of dementia in patients with type 2 diabetes
Reports and Proceedings
Updates every hour. Last Updated: 28-Oct-2026 03:17 ET (28-Oct-2026 07:17 GMT/UTC)
How quickly can a reliable determination be made in people with acute chest pain as to whether a heart attack is present or can be ruled out? Two major international research studies address this question, and their findings were presented last weekend at the European Society of Cardiology (ESC) Congress in Munich. A key figure in this effort is Prof. Jasper Boeddinghaus, who recently moved from the University Hospital of Basel to the University Hospital of Bonn (UKB), where he is establishing the new Institute for Clinical Cardiovascular Science. The international “PRESC1SE-MI” study was published simultaneously in the renowned journal *The Lancet*. A second paper has already been accepted for publication there and will appear shortly.
A research team found that dietary Radix isatidis herbal residue (RIHR), a traditional Chinese medicine by-product, may improve growth, mucosal immunity, gut microbiota, and lipid metabolism in broilers.
New research from Monash University, published in the New England Journal of Medicine and presented concurrently at the European Society of Cardiology Congress 2026, found statins decrease the risk of a first major cardiovascular event by 30 per cent for adults aged over 70 living independently.
The Statins in Reducing Events in the Elderly (STAREE) Trial is the first randomised controlled trial of statin therapy to examine whether the cholesterol-lowering medication could help in older people who have historically been overlooked in clinical trials.
This landmark, ten-year trial analysed the cardiovascular outcomes of almost 10,000 participants.